| Financial Year |
March 31 2023 |
| Monetary Funds |
7,127,463,049.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,900,000.00 |
| Accounts Receivable |
1,851,382,889.80 |
| Advances to Suppliers |
221,003,894.49 |
| Other Receivables |
2,002,747,445.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,182,481,491.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,860,575.77 |
| Other Current Assets |
286,433,442.07 |
| Total Current Assets |
13,866,343,070.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,127,294.60 |
| Long-term Equity Investment |
4,567,302,740.04 |
| Investment Properties |
-- |
| Fixed Assetes |
40,043,752,171.01 |
| Under-construction Projects |
1,182,196,876.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
466,355,469.34 |
| R&D expenses |
15,535,883.10 |
| Goodwill |
41,714,065.48 |
| Long-Term Deferred and Prepaid Expenses |
558,729,097.62 |
| Deferred Income Tax Assets |
11,190,854.93 |
| Other Non-Current Assets |
2,223,274.25 |
| Sub-Total of Non-Current Assets |
47,379,207,412.32 |
| Total Assets |
61,245,550,482.57 |
| Short-Term Loans |
2,073,055,590.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,471,923,365.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
416,154,112.36 |
| Taxes Payable |
338,065,309.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
496,657,330.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,898,289,269.77 |
| Other Current Liabilities |
3,944,949.54 |
| Sub-Total of Current Liabilities |
9,223,964,061.66 |
| Long-term Loans |
17,072,487,414.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,058,734.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
225,749,283.43 |
| Deferred Income Tax Liabilities |
51,298,353.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,720,099,520.96 |
| Total Liabilities |
26,944,063,582.62 |
| Paid-In Capital(Or Share Stock) |
8,126,250,017.00 |
| Capital Surplus |
12,250,042,858.16 |
| Surplus Reserve |
749,763,325.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,728,639,068.03 |
| Minority Stockholder's Interest |
462,435,923.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
33,839,050,976.60 |
| Owner's Equity（Stockholder's Equity） |
34,301,486,899.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
61,245,550,482.57 |
